logo
Select company
Select metric
$ -192.69MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
7
Sector
6
Industry
4
History
-
$ 9.92Close
$ 4.58 - $ 18.35 52-Week Range
Ticker Information

Ticker

PRTA

Company Name

PROTHENA CORP PUBLIC LTD CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROTHENA CORP PUBLIC LTD CO - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRTA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -192.69M
3/31/2025$ -129.93M
12/31/2024$ -148.79M
9/30/2024$ -152.99M
6/30/2024$ -96.34M
3/31/2024$ -139.67M
12/31/2023$ -91.58M
9/30/2023$ 176.13M
6/30/2023$ 151.18M
3/31/2023$ 144.05M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTHENA CORP PUBLIC LTD CO's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -75.78M.
  • Over the past 5 years, PROTHENA CORP PUBLIC LTD CO's average CF - Chg. Cash has been $ 16M.
  • The median CF - Chg. Cash for PROTHENA CORP PUBLIC LTD CO during this period was $ -42.74M
  • PROTHENA CORP PUBLIC LTD CO reached its highest CF - Chg. Cash over the past 5 years at $ 284.22M.
  • The lowest CF - Chg. Cash recorded by PROTHENA CORP PUBLIC LTD CO in the same timeframe $ -192.69M

PROTHENA CORP PUBLIC LTD CO's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ 121.18MCAPR : CAPRICOR THERAPEUTICS INC $ 12.55MLCTX : LINEAGE CELL THERAPEUTICS INC $ 12.61MOCGN : OCUGEN INC $ 11.32MTVRD : TVARDI THERAPEUTICS INC $ -23.8MABSI : ABSCI CORP $ -5.3MRLAY : RELAY THERAPEUTICS INC $ -20.63MSRZN : SURROZEN INC $ 52.63MPRME : PRIME MEDICINE INC $ -1.6MVSTM : VERASTEM INC $ 80.95M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

PRTA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -192.69M

Minimum

Jun 30, 2025

$ 284.22M

Maximum

Sep 30, 2021

$ 16M

Average

$ -42.74M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M